Targeting Gallium to Cancer Cells through the Folate Receptor

The development of gallium(III) compounds as anti-cancer agents for both treatment and diagnosis is a rapidly developing field of research. Problems remain in exploring the full potential of gallium(III) as a safe and successful therapeutic agent or as an imaging agent. One of the major issues is th...

Full description

Bibliographic Details
Main Authors: Nerissa Viola-Villegas, Anthony Vortherms, Robert P. Doyle
Format: Article
Language:English
Published: AboutScience Srl 2008-01-01
Series:Drug Target Insights
Online Access:https://doi.org/10.4137/DTI.S651